mosapride has been researched along with Vomiting in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, Y; Hayashinaka, E; Katayama, Y; Nakaoka, T; Okauchi, T; Onoe, K; Shingaki, T; Takashima, T; Wada, Y; Watanabe, Y | 1 |
| Mine, Y; Oku, S; Yoshida, N | 1 |
2 other study(ies) available for mosapride and Vomiting
| Article | Year |
|---|---|
Exploration of Antiemetics for Osteoporosis Therapy-Induced Nausea and Vomiting Using PET Molecular Imaging Analysis to Gastrointestinal Pharmacokinetics.
Topics: Animals; Antiemetics; Benzamides; Bone Density Conservation Agents; Caco-2 Cells; Gastrointestinal Absorption; Gastrointestinal Motility; Gastrointestinal Tract; Granisetron; Humans; Male; Morpholines; Nausea; Osteoporosis; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Teriparatide; Vomiting | 2016 |
Anti-emetic effect of mosapride citrate hydrate, a 5-HT4 receptor agonist, on selective serotonin reuptake inhibitors (SSRIs)-induced emesis in experimental animals.
Topics: Administration, Oral; Afferent Pathways; Animals; Benzamides; Dogs; Dose-Response Relationship, Drug; Gastric Emptying; Male; Morpholines; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT4 Receptor Agonists; Shrews; Stomach; Vagus Nerve; Vomiting | 2013 |